Overexpression of SUMO-1 in hepatocellular carcinoma: A latent target for diagnosis and therapy of hepatoma

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 3, 2011, Pages 533-541

  Guo, Wu Hua ^a   Yuan, Li Hua ^a   Xiao, Zhi Hua ^a   Liu, Dan ^a   Zhang, Ji Xiang ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Bcl 2 tubulin; Hepatocellular carcinoma (HCC); SiRNA; SUMO 1

Indexed keywords

ALPHA TUBULIN; MYC PROTEIN; PROTEIN BCL 2; SMALL INTERFERING RNA; SUMO 1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; SUMO-1 PROTEIN; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79954436128     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0920-x     Document Type: Article

References (34)

1. Amati B, Brooks MW, Levy N et al (1993) Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72(2):233-245 (Pubitemid 23044938)
2. Bantounas I, Phylactou LA, Uney JB (2004) RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol 33(3):545-557 (Pubitemid 40057555)
3. Brunelle JK, Santore MT, Budinger GR et al (2004) c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxiainducible factor-1. J Biol Chem 279(6):4305-4312 (Pubitemid 38199018)
4. Buschmann T, Fuchs SY, Lee CG et al (2000) SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101(7):753-762
5. Cao X, Bennett RL, May WS (2008) c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. J Biol Chem 283(21):14490-14496
6. Carter S, Bischof O, Dejean A et al (2007) C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol 9(4):428-435 (Pubitemid 46511076)
7. Deyrieux AF, Rosas-Acosta G, Ozbun MA et al (2007) Sumoylation dynamics during keratinocyte differentiation. J Cell Sci 120 (Pt 1):125-136 (Pubitemid 46206655)
8. Di Bacco A, Ouyang J, Lee HY et al (2006) The SUMO-specific protease SENP5 is required for cell division. Mol Cell Biol 26(12):4489-4498 (Pubitemid 43877569)
9. Duan H, Heckman CA, Boxer LM (2005) Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t (14; 18) lymphomas. Mol Cell Biol 25(5):1608-1619 (Pubitemid 40280131)
10. Itahana Y, Yeh ET, Zhang Y (2006) Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2. Mol Cell Biol 26(12):4675-4689 (Pubitemid 43877584)
11. Iyer NG, Chin SF, Ozdag H et al (2004) p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc Natl Acad Sci USA 101(19):7386-7391 (Pubitemid 38638042)
12. Jones MC, Fusi L, Higham JH et al (2006) Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone. Proc Natl Acad Sci USA 103(44):16272-16277 (Pubitemid 44715186)
13. Kang JS, Saunier EF, Akhurst RJ et al (2008) The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol 10(6):654-664 (Pubitemid 351772931)
14. Karamouzis MV, Konstantinopoulos PA, Badra FA et al (2008) SUMO and estrogen receptors in breast cancer. Breast Cancer Res Treat 107(2):195-210 (Pubitemid 50015940)
15. Kim KI, Baek SH (2009) Small ubiquitin-like modifiers in cellular malignancy and metastasis. Int Rev Cell Mol Biol 273:265-311
16. Kim KI, Baek SH, Jeon YJ et al (2000) A new SUMO-1-specific protease, SUSP1 that is highly expressed in reproductive organs. J Biol Chem 275(19):14102-14106 (Pubitemid 30339685)
17. Lee MH, Lee SW, Lee EJ et al (2006) SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 selfubiquitination. Nat Cell Biol 8(12):1424-1431 (Pubitemid 44835118)
18. Martin S, Nishimune A, Mellor JR et al (2007) SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447(7142):321-325 (Pubitemid 46788827)
19. Okuno S, Shimizu S, Ito T et al (1998) Bcl-2 prevents caspaseindependent cell death. J Biol Chem 273(51):34272-34277 (Pubitemid 29008903)
20. Park J, Kim K, Lee EJ et al (2007) Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis. Proc Natl Acad Sci USA 104(43):17028-17033 (Pubitemid 350210985)
21. Pataer A, Fanale MA, Roth JA et al (2006) Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer Gene Ther 13(8):806-814 (Pubitemid 44100494)
22. Pfander B, Moldovan GL, Sacher M et al (2005) SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 436(7049):428-433 (Pubitemid 41059056)
23. Reynolds JE, Eastman A (1996) Intracellular calcium stores are not required for Bcl-2-mediated protection from apoptosis. J Biol Chem 271(44):27739-27743 (Pubitemid 26367345)
24. Rosas-Acosta G, Russell WK, Deyrieux A et al (2005) A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics 4(1):56-72 (Pubitemid 40309325)
25. Saitoh H, Sparrow DB, Shiomi T et al (1998) Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr Biol 8(2):121-124 (Pubitemid 28104526)
26. Seufert W, Futcher B, Jentsch S (1995) Role of a ubiquitinconjugating enzyme in degradation of S-and M-phase cyclins. Nature 373(6509):78-81
27. Song MS, Song SJ, Kim SY et al (2008) The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO J 27(13):1863-1874
28. Sutter AP, Maaser K, Grabowski P et al (2004) Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1. J Hepatol 41(5):799-807 (Pubitemid 39434310)
29. Wang H, Mannava S, Grachtchouk V et al (2008) c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 27(13):1905-1915 (Pubitemid 351430817)
30. Weidtkamp-Peters S, Lenser T, Negorev D et al (2008) Dynamics of component exchange at PML nuclear bodies. J Cell Sci 121:2731-2743
31. Wu F, Zhu S, Ding Y et al (2009) MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res 15(5):1550-1557
32. Xhemalce B, Riising EM, Baumann P et al (2007) Role of SUMO in the dynamics of telomere maintenance in fission yeast. Proc Natl Acad Sci USA 104(3):893-898 (Pubitemid 46154707)
33. Xu GW, Sun ZT, Forrester K et al (1996) Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. Hepatology 24(5):1264-1268 (Pubitemid 26365936)
34. Yurchenko V, Xue Z, Sadofsky MJ (2006) SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair. Mol Cell Biol 26(5):1786-1794